Most Read Articles
3 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, 3 days ago
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Home-based disability prevention programme boosts life-space, falls efficacy in seniors

26 Oct 2020
Singapore’s Ageing Population: New campaign launched to prevent falls

A home-based, multicomponent disability prevention programme is helpful for improving life-space and falls efficacy among elderly adults, a recent study has found.

Life-space, a measure of mobility defined by the distance a person routinely covers over a specified time period, was assessed in 194 elderly adults using the Homebound Mobility Assessment. Falls efficacy, on the other hand, was evaluated in 233 participants using the 10-item Tinetti Falls Efficacy Scale and refers to the perceived confidence for avoiding falls during essential daily activities.

Both outcomes were measured before and after the disability prevention programme, which included up to six 1-hour home visits from an occupational therapist (OT), and up to four 1-hour visits from a nurse. In addition, they were allowed home repairs and installations of assistive devices, all according to OT recommendations.

After 5 months, the researchers observed significant improvements in life-space across various home areas, such as the stairs (adjusted odds ratio [OR], 4.09, 95 percent confidence interval [CI], 1.34–12.48) and the bathroom (adjusted OR, 3.95, 95 percent CI, 1.20–12.97).

Similarly, life-space improvements were found for leaving the house for any reason other than healthcare (adjusted OR, 2.40, 95 percent CI, 1.01–5.73), as well as for the overall life-space score (adjusted OR, 2.15, 95 percent CI, 1.10–4.19).

The intervention also led to a significant improvement in total falls efficacy (adjusted OR, 1.12, 95 percent CI, 1.04–1.21). Those who saw improvements in their life-space also showed the greatest increase in falls efficacy.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, 3 days ago
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.